ArticleOncology letters2021

Targeting Mps1 in combination with paclitaxel inhibits osteosarcoma progression by modulating spindle assembly checkpoint and Akt/mTOR signaling.

Lu Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.